Full text is available at the source.
Abstract
In vivo experiments demonstrated high luciferase expression in the spleen and liver following intravenous injection of nanoparticle carriers.
- Conventional mRNA nanoparticle carriers face challenges in efficient release into the cytoplasm due to endosomal degradation.
- A novel class of lipoic acid derivative composite nanoparticles was designed to facilitate direct mRNA release into the cytoplasm.
- Surface disulfide bonds on the nanoparticles allow them to anchor to cell membranes, bypassing the endosomal pathway.
- In vitro optimization identified three formulations that were particularly effective for mRNA delivery.
- Thiol-mediated uptake was observed as the main pathway for internalization of the nanoparticles.
Simplified